John Simmons

John Simmons is a well-educated, accomplished professional in the biopharma industry, with a focus on oncology and cancer biology. He holds a BS in Biology, with University Honors, from American University, as well as a Ph.D. in Tumor Biology and a Ph.D. in Oncology and Cancer Biology, both from Georgetown University.

Simmons has an impressive background, having held several positions in notable organizations. He is currently the Global Vice President of Biopharma Business Development at Natera, where he leverages his expertise to help the company deliver cutting-edge solutions to address critical unmet medical needs. Prior to Natera, he held positions at Personal Genome Diagnostics, where he served as the VP of Translational Medicine and Director and Manager of Translational Science & Diagnostics.

Before his time in the private sector, Simmons was a Postdoctoral Fellow and Predoctoral Fellow at the National Cancer Institute (NCI), where he focused on cancer biology and worked on various projects that aimed to develop innovative cancer therapies.

Overall, John Simmons is an acclaimed professional with a wealth of knowledge and experience in the biopharma industry. His expertise in oncology and cancer biology makes him an important player in the field, and his contributions have undoubtedly helped advance research and development efforts aimed at finding innovative treatments for cancer patients.